The synthesis of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Preliminary routes focused on protein section coupling, utilizing solid-phase creation methodologies to build the long peptide sequence. Subsequent investigation has explored different approaches, including